White House chief of staff Susie Wiles has been named co-chair of a new women’s health task force, a role that lands just days after rumors swirled about her future in the West Wing.
President Donald Trump signed an executive order Monday in the Rose Garden establishing the task force and a new Women’s Health Division at the National Institutes of Health. Wiles will co-chair the effort with Health and Human Services Secretary Robert F. Kennedy Jr., working alongside First Lady Melania Trump on an initiative framed as a push to improve research, diagnosis, and treatment of conditions that hit women hardest.
The US Sun reported that Wiles, 69, sat in the front row in her trademark aviator sunglasses before joining the president and first lady on stage. Trump handed her one of the pens used to sign the order. The division at NIH must be stood up within 90 days. The order sets no specific funding targets.
The timing was deliberate. The ceremony fell during Breast Cancer Awareness Month, just weeks after Wiles announced she was cancer-free and only days after speculation intensified over whether she would remain chief of staff.
Trump made the point himself from the podium.
"As many of you know, Susie recently won her battle against a very tough opponent, breast cancer."
He added that she is “tough” and “a tremendous fighter.” He also insisted there was “zero chance” of her being fired and said she was “going to be here for a long time.”
Wiles did not treat the appointment as a last-minute save. She told the New York Post the move was “long planned” and called the initiative “Mrs Trump’s brainchild, strategy and emphasis.”
"It just makes sense, as the first female Chief of Staff who battled cancer, I am honored to be asked to be a part of this incredibly important work by her."
On social media after the ceremony, she thanked Melania Trump directly.
"I am especially grateful for first lady Melania Trump‘s leadership in championing women’s health. This is deeply personal to me. Having gone through breast cancer myself, I know firsthand the importance of early detection, medical research, and quality care. I am grateful to the President and First Lady for their commitment to helping women live longer, healthier lives."
Trump adviser Alex Bruesewitz welcomed the choice in similar terms, noting Wiles is the first woman to serve as White House chief of staff and a recent breast cancer survivor who brings “both historic leadership and hard-won personal experience.”
The ceremony arrived after a stretch of West Wing chatter. Reports described internal disagreements ahead of November’s midterm elections. Questions also followed a New York Post account that Trump had appointed Katie Zacharia as press secretary without consulting his chief of staff.
Trump’s public message Monday cut the other way. He praised Wiles’ cancer fight, put her on stage, handed her the pen, and said flatly she was staying. The first lady had already reached out to Wiles earlier this year while she was undergoing treatment, and the two have maintained a cordial working relationship.
Wiles helped steer Trump’s successful 2024 presidential campaign and became the first woman to hold the chief of staff job when he returned to office. Nicknamed the “Ice Maiden,” she has kept a low public profile while running the West Wing. The new co-chair role puts her personal medical history and her institutional rank in the same frame.
The order creates a White House task force on women’s health to coordinate work across federal agencies. It also directs creation of a Women’s Health Division inside the National Institutes of Health within 90 days. The focus areas listed include heart disease, endometriosis, osteoporosis, and other conditions that disproportionately affect women.
The panel’s job, as described, is to improve research, diagnosis, and treatment. No dollar figures or multi-year budget lines were attached in the public description of the order. That leaves the practical weight of the effort to later staffing, agency follow-through, and whatever resources the administration assigns once the division is stood up.
Kennedy, as HHS secretary, will share the co-chair duties with Wiles. Melania Trump’s role is cast as the strategic driver of the initiative rather than a formal co-chair title in the reporting. Wiles’ public comments consistently credit the first lady with the concept and the emphasis.
Wiles’ cancer diagnosis, treatment earlier this year, and recent all-clear gave the Rose Garden event a personal edge the White House did not hide. Trump named the disease from the podium. Wiles answered with her own record of early detection and care. The first lady’s earlier outreach during treatment supplied a private thread that later became public policy theater.
For a chief of staff already under the usual West Wing pressure, the optics were clear: the president was not distancing himself from her. He was folding her recovery into a signature health initiative and putting her name on it.
Whether the task force and the new NIH division produce measurable gains in women’s health research will depend on execution after the 90-day clock starts. The order itself is the starting gun, not the finished product. Funding levels remain unsettled in the public text. Membership beyond the co-chairs was not laid out in detail.
What Monday did settle, at least in public, was the immediate personnel question. Exit rumors met a signed order, a stage appearance, a presidential endorsement, and a co-chair title tied to the first lady’s stated priority. Wiles left the Rose Garden with the pen and the assignment.
In a White House that rewards loyalty and results, the chief of staff just got a very public vote of confidence, and a job that matches the fight she already won.
